Compound Detail
CHEMBL741
LAMOTRIGINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL741 |
| Name | LAMOTRIGINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | PYZRQGJRPPTADH-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
12
Targets
36
Activities
2
Assay Types
13
PK Parameters
20
Publications
9
Known Names
20
Indications
1
Mechanisms
Molecular Properties
256.1
MW (Da)
2.01
ALogP
5
HBA
2
HBD
90.7
PSA (Ų)
0.81
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1994 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Sodium channel alpha subunit blocker | BLOCKER | Sodium channel alpha subunit | ✓ | ✓ |
Indications
Bipolar Disorder Bipolar Disorder Depressive Disorder Depressive Disorder Epilepsies, Partial Epilepsy Epilepsy, Tonic-Clonic Epilepsy, Tonic-Clonic Lennox Gastaut Syndrome Seizures Anxiety Dementia Epilepsy, Absence Feeding and Eating Disorders Mood Disorders Obesity Pain Peripheral Nervous System Diseases Schizophrenia Alcoholism
ATC Classification
N03AX09
lamotrigine
Level 1: NERVOUS SYSTEM
Level 2: ANTIEPILEPTICS
Drug Warnings
Black Box Warning
dermatological toxicity
Activity Summary
IC50 33 meas. best 5.58
Ki 3 meas. best 4.82
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 5.58 | 4.625 | 2600.0 | 8 |
| Sodium channel protein type 2 subunit alpha CHEMBL4187 | IC50 | 5.0 | 4.885 | 10000.0 | 2 |
| Dihydrofolate reductase CHEMBL1809 | Ki | 4.82 | 4.82 | 15240.0 | 1 |
| Sodium channel protein type 4 subunit alpha CHEMBL2072 | Ki | 4.77 | 4.77 | 17000.0 | 1 |
| Sodium channel protein type 9 subunit alpha CHEMBL4296 | IC50 | 4.77 | 4.77 | 17000.0 | 1 |
| Sodium channel protein type 3 subunit alpha CHEMBL5163 | IC50 | 4.77 | 4.77 | 17000.0 | 1 |
| Sodium channel protein type 10 subunit alpha CHEMBL4017 | IC50 | 4.6 | 4.6 | 25000.0 | 1 |
| Nucleic Acid CHEMBL345 | Ki | 4.54 | 4.54 | 29200.0 | 1 |
| Sodium channel alpha subunits; brain (Types I, II, III) CHEMBL2095171 | IC50 | 4.51 | 4.51 | 31000.0 | 1 |
| Sodium channel protein type 2 subunit alpha CHEMBL3399 | IC50 | 4.46 | 4.46 | 35000.0 | 2 |
| Sodium channel protein type 5 subunit alpha CHEMBL1980 | IC50 | 4.4 | 4.2033 | 39810.7 | 3 |
| Sodium channel protein type 10 subunit alpha CHEMBL5451 | IC50 | 4.02 | 4.015 | 96000.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 1.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.6 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.6 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.4 | mL.min-1.kg-1 | Mus musculus |
| CL | 1.4 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| Cmax | 13666.54 | nM | Rattus norvegicus |
| F | 80.0 | % | Homo sapiens |
| F | 79.0 | % | Rattus norvegicus |
| Fu | 0.51 | - | Rattus norvegicus |
| Fu | 0.21 | - | Rattus norvegicus |
| Fu | 0.45 | - | Homo sapiens |
| T1/2 | 10.1 | hr | Mus musculus |
| Vd | 4.6 | L.kg-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine